Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer

Rochelle E. Curtis, D. Michal Freedman, Mark E. Sherman, Joseph F. Fraumeni

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences